Recent lineage studies suggest that hematopoietic stem cells (HSCs) may be derived from endothelial cells. However, the genetic hierarchy governing the emergence of HSCs remains elusive. We report here that zebrafish etsrp, which is essential for vascular endothelial development, also plays a critical role in the initiation of definitive hematopoiesis by controlling the expression of two scl isoforms (scl-α and scl-β) in angioblasts. In etsrp morphants, which are deficient in endothelial and HSC development, scl-α alone partially rescues angioblast specification, arterial-venous differentiation and the expression of HSC markers, runx1 and cmyb, while scl-β requires angioblast rescue by fli1a to restore runx1 expression. Interestingly, when Vegf signaling is inhibited, HSC marker expression can still be restored by scl-α in etsrp morphants, while the rescue of arterial ephrinb2a expression is blocked. Furthermore, both scl isoforms partially rescue runx1 but not ephrinb2a expression in embryos deficient in Vegf signaling. Our data suggest that downstream of etsrp, scl-α and fli1a specify the angioblasts, while scl-β further initiates HSC specification from this angioblast population, and that Vegf signaling acts upstream of scl-β during definitive hematopoiesis.
Introduction
Vertebrate hematopoiesis proceeds in two waves: primitive hematopoiesis which serves as a transient early source of limited blood cell types and definitive hematopoiesis which contributes to all adult blood lineages. In zebrafish, the first apparent definitive hematopoietic stem cells (HSCs) or their precursors are marked by the expression of runx1 and c-myb along the ventral wall of the dorsal aorta (DA) 1, 2 , the functionally equivalent structure of the mouse aorta-gonadmesonephros (AGM) region. These aortic HSCs will later seed the caudal hematopoietic tissue,
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From thymus and kidney [3] [4] [5] . Accumulating evidence suggests that the HSCs may be derived from endothelial progenitors through a hemogenic endothelial intermediate [6] [7] [8] . Although these studies define a lineage relationship during definitive hematopoiesis, the genetic program directing HSC specification remains elusive.
Previous studies have established the stem cell leukemia (scl) gene as a critical transcription factor controlling vertebrate hematopoiesis. Scl marks both hematopoietic and endothelial precursors during early vertebrate development 9, 10 . When over-expressed, scl expands both angioblasts and erythroblasts in zebrafish embryos 9 , and partially restores the expression of markers of both lineages in the zebrafish cloche mutants which are devoid of blood and vessel development 11 . In loss-of-function studies, scl deficiency abolishes both primitive and definitive hematopoiesis in mice 12, 13 and zebrafish [14] [15] [16] . Two isoforms of scl, the full-length scl-α and the N-terminal truncated scl-β, have been identified in zebrafish, which function redundantly in primitive erythropoiesis and myelopoiesis. However, only scl-β is required for definitive hematopoiesis in vivo, although both isoforms are able to rescue HSC marker expression in sclsplicing morphants where both isoforms are disrupted 16 . A recent report in mice further demonstrates that Scl is an indispensable factor for the establishment of the hemogenic endothelium 8 . Thus, identifying the genetic program controlling the dynamic expression of scl during definitive hematopoiesis will contribute to our knowledge of the mechanism underlying HSC emergence and how this process is coordinated with endothelial development.
The Vegf receptor, fetal liver kinase 1 (flk1), and the transcription factor, ets1-related protein (etsrp), have been indicated as upstream regulators of scl in vertebrates. Flk1 -/-mutant mice fail to develop both endothelial and hematopoietic cells 17 , which can be rescued by ectopic scl expression under the Flk1 promoter in vitro 18 . Etsrp plays an essential role during angioblast specification and primitive myelopoiesis in zebrafish [19] [20] [21] [22] . Similarly, knockout of its mammalian
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From homolog, Etv2/Er71, also leads to severe defects in both hematopoietic and endothelial development in mice 23 . Epistasis analysis in zebrafish shows that the myelopoietic defect in etsrp morphants can be rescued by scl over-expression 22 .
In this study, we analyzed the interplay among etsrp, scl and Vegf signaling in directing the definitive hematopoietic program. Here we show that etsrp is required for HSC initiation and that both scl isoforms function downstream of etsrp in this process. Etsrp controls scl expression in angioblasts of the PLPM. We examined the potential of both scl isoforms to rescue the endothelial and HSC defects in etsrp morphants, and found that scl-α alone restores both angioblast and HSC marker expression, while scl-β does not. Nonetheless, scl-β partially rescues runx1 expression when angioblasts are first restored by fli1a over-expression.
Furthermore, we found that the rescue of arterial and HSC marker expression by scl-α in etsrp morphants can be uncoupled by inhibition of Vegf signaling, wherein over-expression of scl-α can bypass the requirement of arterial identity and Vegf signaling for HSC initiation. This suggests that scl plays a role downstream of Vegf signaling in the initiation of definitive hematopoiesis. This idea is further supported by the partial rescue of runx1 expression by both scl isoforms in Vegf signaling-deficient embryos produced by either SU5416 treatment or plcg1 knockdown. Our findings define genetic programs downstream of etsrp during angioblast specification and HSC emergence.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From cloned into the pCS2+ vector for mRNA synthesis. To make an scl-3' probe that recognizes both scl isoforms 16 , the coding sequence of scl-β was also cloned into the pCR2.1-TOPO cloning vector (Invitrogen). To make an scl-5' probe that only recognizes scl-α 16 , an scl fragment that covers the most 5' region of scl-α transcript including its 5'UTR was PCR amplified using primers: forward, 5'-ACATGGATGACCCTCCACAAAATG-3', reverse, 5'-CGCTCCCTCCTCTCCTGGAC-3', and was cloned into the pCR2.1-TOPO cloning vector.
Microinjection of morpholinos and mRNAs
A mixture of two etsrp-specific morpholinos (Gene Tools) was used as described 19 . A mixture of two tbx16-specific morpholinos (Gene Tools) was also used as described
27
. An scl morpholino (Open Biosystems) designed to block the proper splicing of both scl isoforms has been described previously 15 , and was injected at a dose of 8 ng. A plcg1 morpholino (Open Biosystems) has been described previously 28 , and was injected at a dose of 15 ng.
The mRNAs of etsrp 19 , scl-α, scl-β, ets1a, fli1a, fli1b and erg were synthesized using mMessage mMachine Kit (Ambion), and injected at the following doses: etsrp (75 pg), scl-α (100 pg), scl-β (200 pg), ets1a (200 pg), fli1a (10 pg), fli1b (10 pg) and erg (10 pg). In rescue experiments, embryos were injected sequentially with morpholinos and mRNAs. All injections were made at the one-cell stage.
Chemical treatment
SU5416 (Sigma-Aldrich) was dissolved in DMSO at a stock concentration of 1 mM. Embryos were treated with SU5416 at 2 μ M starting from 12 hpf until fixation at desired stages, while control embryos were treated with 0.2% DMSO.
Whole-mount in situ hybridization
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From For single-color in situ hybridization, antisense riboprobes were labeled with digoxygenin (DIG) (Roche). The following probes were used: runx1, c-myb, rag1, scl-3', scl-5', lmo2, flk1, gata1, ephrinb2a and flt4. Whole-mount in situ hybridization was performed as described 29 .
Double fluorescent in situ hybridization was performed as described 30 , except that biotintyramide (PerkinElmer; 1:25 dilution) followed by streptavidin-fluorescein (PerkinElmer; 1:400 dilution) was used for amplification and detection of the DIG signal. To compare the expression of etsrp with that of scl and gata1, etsrp was labeled with DIG, while scl and gata1 were labeled with dinitrophenol (DNP) (Mirus Bio LLC.). To compare the expression of runx1 with that of primitive hematopoietic markers in etsrp morphants over-expressing scl-α, lcp1, mpx and gata1
were labeled with DIG, while runx1 was labeled with DNP.
Imaging
Images of single-color in situ hybridization and flk1-GFP were taken using Axioskop 2 plus microscope (Zeiss) with 10X magnification and Openlab 4.0 software (Improvision). For imaging the flk1-GFP embryos, images of both green fluorescence and bright field were taken and merged using Adobe Photoshop. The brightness and contrast of images was adjusted using Adobe Photoshop. Numbers in the lower right corner of each panel denote the number of embryos with the observed phenotype over the total observed. Images of double fluorescent in situ hybridization were taken using LSM 510 confocal microscope (Zeiss) with 20X magnification and LSM image software. Unless otherwise noted, images show the lateral view with anterior to left.
Quantitative PCR
For real-time quantitative PCR (qPCR) analysis, RNA was isolated with Trizol (Invitrogen), and equal quantities of cDNA were reverse transcribed between groups with superscript II For personal use only. on October 3, 2017. by guest www.bloodjournal.org From (Invitrogen). qPCR was performed using the iCycler iQ Real-Time PCR Detection System (BioRad) with iQ SYBR Green Supermix (BioRad). Gene expression levels were analyzed using the Δ Δ C t method, with β -actin serving as the reference gene. Measurements were made in triplicate from three independent biological replicates per condition, and the fold-changes reported reflect the comparison of experimental groups relative to un-injected control at the time points stated in the result section. Independent student t-tests were used for statistical analysis.
Primers used: scl-α: forward, 5'-CTGAAATCCGAGCAATTTCC-3', reverse, 5'-
Results

Etsrp is required for the initiation of definitive hematopoiesis
In the mouse AGM region, VE-cadherin + endothelium instead of its underlying mesenchyme is capable of HSC emergence 6 . This suggests a close lineage relationship between endothelial cells and HSCs, which is also supported by observations in zebrafish 3, 4 . Given the critical requirement of etsrp for endothelial development 19-21 , we examined whether etsrp is also required for definitive hematopoiesis. Runx1 and c-myb expression in the ventral wall of the DA has been shown to mark the emergence of HSCs or their precursors in zebrafish 1, 2 , their expression were therefore analyzed on zebrafish embryos at 30 hpf and 40 hpf, respectively. In etsrp morphants, both markers were missing in the ventral wall of the DA (Fig.1A-D (Fig.2H) , from the caudal PLPM in tbx16 morphants (Fig.2I) , and from the entire PLPM in etsrp/tbx16 double morphants (Fig.2J ). This indicates that scl expression in angioblasts and erythroblasts is controlled separately by etsrp and tbx16, respectively. Similar result was observed when we used the scl-5' probe that specifically recognizes scl-α ( Fig.2K-N) , except that the expression in the rostral PLPM detected by the scl-5' probe ( Fig.2K and M) was much weaker than that detected by the scl-3' probe ( Fig.2G and I ). This may be explained by the lower sensitivity of the shorter scl-5' probe or the presence of scl-β in angioblasts, however, an scl-β-specific probe cannot be made, because the scl-β mRNA overlaps entirely with the 3' part of the scl-α mRNA. The regulatory mechanism revealed above is not specific for scl, as lmo2, which shares a similar expression pattern with scl and has been suggested to function together with scl in both hematopoietic and endothelial development [31] [32] [33] , was regulated in a similar manner (Fig.S1 ).
To further analyze the regulation of both scl isoforms by etsrp, we performed qPCR analysis with one pair of primers amplifying an scl-α-specific fragment, and another pair amplifying a common fragment to both scl isoforms (scl-α & -β). In 10-hpf embryos over-expressing etsrp mRNA, scl-α was up-regulated by two-fold (2.11±0.37, p<0.05), while scl-α & -β together were up-regulated by ten-fold (10.66±3.6, p<0.05) (Fig.2K) . In 14-hpf etsrp morphants, scl-α was slightly decreased (0.73±0.31, p=0.22), while scl-α & -β together were decreased ~70% compared to control (0.31±0.04, p<0.00005) (Fig.2L ). This further supports that scl-β is present 1 1 in angioblasts, and indicates that etsrp is both sufficient and necessary to induce the expression of both scl isoforms in angioblasts.
Scl-α partially rescues both angioblast specification and HSC initiation in etsrp morphants
Both trunk endothelial cells and HSCs, which are derived from angioblasts in the PLPM, are deficient in etsrp morphants (Fig.1 ) [19] [20] [21] . Since etsrp controls the expression of both scl isoforms in angioblasts, we examined the potential of both scl isoforms to rescue the endothelial and HSC defects in etsrp morphants. Flk1-GFP transgenic embryos were used to visualize the vascular phenotype 26 . In etsrp morphants injected with scl-α mRNA, the expression of flk1-GFP in axial vessels as well as the sprouting of intersomitic vessels (ISVs) was partially recovered when analyzed at 30 hpf ( Fig.3C ), while injection of scl-β mRNA did not produce significant rescue (Fig.3D ). This rescue of flk1-GFP expression was not obvious during the initial hours of endogenous flk1 expression, which is consistent with our previous observation 22 , but became evident thereafter. To further evaluate the recovery of the endothelial cell fate, we examined the expression of differentiated arterial marker ephrinb2a and venous marker flt4, which were both absent in etsrp morphants ( Fig.S2B and E). In etsrp morphants injected with scl-α mRNA, ephrinb2a was partially restored, which was generally restricted to the anterior trunk region ( Fig.S2C ), while flt4 was restored to a level comparable to that of wild-type embryos (Fig.S2F ).
We then extended our analysis to HSC markers, runx1 and c-myb. Again, only scl-α ( 
Scl-β partially rescues runx1 expression in etsrp morphants when an angioblast basis is first restored by fli1a over-expression
Scl-β is reported to have lower protein stability than scl-α 16 , which may contribute to its inability to rescue the endothelial and HSC defects in etsrp morphants. To examine this possibility, we further compared the functional potentials of the two isoforms. It is known that both scl isoforms function redundantly during primitive erythropoiesis 16 , and we were able to rescue gata1 expression in scl-splicing morphants with mRNA injections for either scl-α or scl-β ( Fig.S4 ), which validates that the synthetic mRNA encoding scl-β is functional. Scl-α is known to expand both angioblasts and erythroblasts, when over-expressed 9 . Here we tested if scl-β is as effective. Over-expression of both scl-α and scl-β ectopically expanded erythroblasts at 14 hpf, as indicated by gata1 expression (Fig.4D-F to rescue runx1 expression in etsrp morphants. As shown here, etsrp morphants co-injected with the mRNAs of both scl-β and fli1a displayed restored runx1 expression (Fig.4M ). This indicates that the ability of scl-β to restore runx1 expression in etsrp morphants requires an angioblast rescue that can be provided by fli1a over-expression, although possible synergistic effects between scl-β and fli1a during angioblast specification or HSC initiation cannot be ruled out.
HSC initiation can proceed without arterial differentiation
It is known that proper angioblast development is characterized by the expression of Vegf receptors, and that both arterial-venous differentiation and angiogenesis is supported by Vegf The Vegf signaling-independent rescue of HSC initiation by scl-α in etsrp morphants suggests a downstream role of scl relative to Vegf signaling during definitive hematopoiesis. To further explore this possibility, we over-expressed either scl isoform in SU5416-treated embryos which were devoid of both ephrinb2a (Fig.6F ) and runx1 (Fig.6B ) expression. Scl-α partially rescued runx1 expression in SU5416-treated embryos (Fig.6C) . Interestingly, scl-β, which was unable to rescue runx1 expression in etsrp morphants, also partially rescued runx1 expression in SU5416-treated embryos (Fig.6D ), although to a lesser extent than scl-α did (Fig.6C ). This is likely due to the fact that scl-α but not scl-β is able to expand the angioblast population 9, 14, 32 , which serves as the progenitor pool that gives rise to HSCs. However, neither scl isoform was able to rescue ephrinb2a expression in SU5416-treated embryos ( Fig.6G and H) . To verify the results from SU5416 treatment, we inhibited Vegf signaling alternatively with a morpholino targeting plcg1, an effector of Vegf signaling 28, 39 . Similarly, runx1 expression in the ventral wall of the DA was absent in plcg1 morphants (Fig.S5B ) 36 , and can be partially rescued by the overexpression of either scl-α (Fig.S5C ) or scl-β (Fig.S5D) [19] [20] [21] , etsrp also makes a direct contribution to definitive hematopoiesis by inducing scl-β (Fig.7) .
However, we failed to rescue runx1 expression in etsrp morphants by over-expressing scl-β alone. Nonetheless, scl-β is sufficient to induce HSC marker expression under three conditions:
scl-splicing morphants 16 , etsrp morphants with fli1a over-expression and Vegf signalingdeficient embryos produced by either SU5416 treatment or plcg1 knockdown. In all three circumstances, angioblast specification occurs properly 14, 37 , which suggests that scl-β requires an endothelial basis to promote definitive hematopoiesis.
In this study, we show that scl-α alone partially rescues the expression of both endothelial and HSC markers in etsrp morphants. Although scl-α is not required for definitive hematopoiesis in vivo 16 , given that it has the same hematopoietic potential as scl-β does 16 and is able to restore angioblasts in etsrp morphants, it is not surprising that forced and prolonged expression of scl-α also restores runx1 expression in etsrp morphants. Our data suggest that scl acts in two waves downstream of etsrp during definitive hematopoiesis. In the first wave, scl-α promotes angioblast specification, and in the second wave, scl-β further promotes HSC emergence on this angioblast basis (Fig.7) .
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